These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 26332830)

  • 1. Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease.
    Weinreb O; Amit T; Bar-Am O; Youdim MB
    Br J Pharmacol; 2016 Jul; 173(13):2080-94. PubMed ID: 26332830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flurbiprofen-chalcone hybrid Mannich base derivatives as balanced multifunctional agents against Alzheimer's disease: Design, synthesis and biological evaluation.
    Tian C; Qiang X; Song Q; Cao Z; Ye C; He Y; Deng Y; Zhang L
    Bioorg Chem; 2020 Jan; 94():103477. PubMed ID: 31818478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases.
    Mathew B; Parambi DGT; Mathew GE; Uddin MS; Inasu ST; Kim H; Marathakam A; Unnikrishnan MK; Carradori S
    Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900177. PubMed ID: 31478569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From anti-Parkinson's drug rasagiline to novel multitarget iron chelators with acetylcholinesterase and monoamine oxidase inhibitory and neuroprotective properties for Alzheimer's disease.
    Zheng H; Amit T; Bar-Am O; Fridkin M; Youdim MB; Mandel SA
    J Alzheimers Dis; 2012; 30(1):1-16. PubMed ID: 22387411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-activated multi target iron chelators with acetylcholinesterase (AChE) and monoamine oxidase (MAO) inhibitory activities for Alzheimer's disease therapy.
    Youdim MBH
    J Neural Transm (Vienna); 2022 Jun; 129(5-6):715-721. PubMed ID: 35190910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands.
    Iraji A; Khoshneviszadeh M; Firuzi O; Khoshneviszadeh M; Edraki N
    Bioorg Chem; 2020 Apr; 97():103649. PubMed ID: 32101780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer's disease.
    Zhang X; Song Q; Cao Z; Li Y; Tian C; Yang Z; Zhang H; Deng Y
    Bioorg Chem; 2019 Jun; 87():395-408. PubMed ID: 30921741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease.
    Sang Z; Wang K; Shi J; Liu W; Tan Z
    Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, in-silico and biological evaluation of novel chalcone derivatives as multi-function agents for the treatment of Alzheimer's disease.
    Sang Z; Wang K; Zhang P; Shi J; Liu W; Tan Z
    Eur J Med Chem; 2019 Oct; 180():238-252. PubMed ID: 31310916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer's disease.
    Knez D; Sova M; Košak U; Gobec S
    Future Med Chem; 2017 May; 9(8):811-832. PubMed ID: 28504893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro and In Vivo Investigations of Chromone Derivatives as Potential Multitarget-Directed Ligands: Cognitive Amelioration Utilizing a Scopolamine-Induced Zebrafish Model.
    Kumar N; Jangid K; Kumar V; Yadav RP; Mishra J; Upadhayay S; Kumar V; Devi B; Kumar V; Dwivedi AR; Kumar P; Baranwal S; Bhatti JS; Kumar V
    ACS Chem Neurosci; 2024 Jul; 15(14):2565-2585. PubMed ID: 38795037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine oxidase inhibitors: promising therapeutic agents for Alzheimer's disease (Review).
    Cai Z
    Mol Med Rep; 2014 May; 9(5):1533-41. PubMed ID: 24626484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer's agents.
    Košak U; Knez D; Coquelle N; Brus B; Pišlar A; Nachon F; Brazzolotto X; Kos J; Colletier JP; Gobec S
    Bioorg Med Chem; 2017 Jan; 25(2):633-645. PubMed ID: 27908752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa Youdim.
    Weinreb O; Mandel S; Bar-Am O; Amit T
    J Neural Transm (Vienna); 2011 Mar; 118(3):479-92. PubMed ID: 21360301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of oxidative stress and other pathologies in Alzheimer's disease.
    Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
    Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarsasapogenin: A steroidal saponin from Asparagus racemosus as multi target directed ligand in Alzheimer's disease.
    Kashyap P; Muthusamy K; Niranjan M; Trikha S; Kumar S
    Steroids; 2020 Jan; 153():108529. PubMed ID: 31672628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review on flavonoid-based scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer's disease.
    Jalili-Baleh L; Babaei E; Abdpour S; Nasir Abbas Bukhari S; Foroumadi A; Ramazani A; Sharifzadeh M; Abdollahi M; Khoobi M
    Eur J Med Chem; 2018 May; 152():570-589. PubMed ID: 29763806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-alkylpiperidine carbamates as potential anti-Alzheimer's agents.
    Košak U; Strašek N; Knez D; Jukič M; Žakelj S; Zahirović A; Pišlar A; Brazzolotto X; Nachon F; Kos J; Gobec S
    Eur J Med Chem; 2020 Jul; 197():112282. PubMed ID: 32380361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of benzamide-hydroxypyridinone hybrids as potent multi-targeting agents for the treatment of Alzheimer's disease.
    Jiang X; Guo J; Zhang C; Gu J; Zhou T; Bai R; Xie Y
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):2045-2054. PubMed ID: 34607518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.